Physician profile
Bryan Criswell
NPI 1487667267
$5,665.82
in general payments reported to CMS, 2019-2025
12 companies · $72.98 in 2025
The $72.98 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,393 · 2020: $188 · 2021: $224 · 2022: $720 · 2023: $526 · 2024: $543 · 2025: $72.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766 · Consulting Fee: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.41 |
| Consulting Fee | $375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,181.66 | 2019-2022 | |
| Merz North America, INC. | $1,309.19 | 2019-2024 | Xeomin |
| Microaire Surgical Instruments LLC | $875.00 | 2022-2023 | Pal |
| Sientra, INC. | $410.86 | 2019-2022 | |
| Mentor Worldwide LLC | $332.32 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $246.04 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Acelrx Pharmaceuticals, INC. | $87.19 | 2019-2021 | |
| Galderma Laboratories, L.P. | $85.36 | 2022-2025 | |
| Tepha INC | $69.17 | 2019 | |
| Heron Therapeutics, INC. | $24.83 | 2023 | Aponvie |
| Trevena, INC. | $22.72 | 2021 | |
| Motiva USA, LLC | $21.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Criswell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.